Table 1.
Baseline Patient Characteristics
| Placebo (N=104) | Testosterone (N=104) | |
|---|---|---|
| Age years [mean (SD)] | 60.1 (9.7) | 59.9 (8.7) |
|
Race
White |
94 (90%) |
100 (96%) |
| Black or African American | 4 (4%) | 2 (2%) |
| Asian | 3 (3%) | 2 (2%) |
| Not reported or unknown | 3 (3%) | 0 (0%) |
|
Ethnicity
Hispanic |
7 (7%) |
9 (9%) |
| Non-Hispanic | 96 (92%) | 93 (89%) |
| Not reported or unknown | 1 (1%) | 2 (1%) |
|
AI Duration
<6 months |
27 (26%) |
14 (14%) |
| 6–12 months | 24 (23%) | 26 (25%) |
| >12 months Missing |
52 (50%) 1 | 63 (61%) 1 |
|
Baseline weight [mean (SD)] Weight in Kg |
71.3 (12.2) |
75.5 (12.8) |
| BMI1 | 26.8 (4.2) | 28.2 (4.2) |
|
ECOG PS2
0 |
81 (78%) |
81 (78%) |
| 1 | 23 (22%) | 20 (19%) |
| 2 | 0 (0%) | 3 (3%) |
| Baseline Average Pain Score [mean (SD)] | 5.5 (1.8) | 5.4 (1.7) |
1
Body Mass Index 2
2
Eastern Cooperative Oncology Group Performance Status